Maternal subclinical hypothyroidsm and gestational diabetes mellitus: A meta-analysis

Endocrine Practice

Volumn 20, Issue 7, 2014, Pages 703-714

  Toulis, Konstantinos A ^a   Stagnaro Green, Alex ^b   Negro, Roberto ^c  

^a 424 General Army Hospital   (Greece)

^b UNIVERSITY OF ILLINOIS   (United States)

^c VITO FAZZI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPARATIVE STUDY; DISEASE ASSOCIATION; EUTHYROIDISM; HUMAN; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; REVIEW; RISK ASSESSMENT; SUBCLINICAL HYPOTHYROIDISM; COMPLICATION; DIABETES, GESTATIONAL; FEMALE; HYPOTHYROIDISM; META ANALYSIS; PREGNANCY; PREGNANCY COMPLICATION;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOTHYROIDISM; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84905012373     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13440.RA     Document Type: Review

References (37)

1. Stagnaro-Green A, Pearce E. Thyroid disorDers in pregnancy. Nat Rev Endocrinol. 2012;8:650-658
2. Expert Committee on the Diagnosis and ClassifiCAtion of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and ClassifiCAtion of Diabetes Mellitus. Diabetes CAre. 1997;20:1183-1197
3. National Institutes of Health. National Diabetes Statistics, 2011. Available at: http://http://diabetes.niddk.nih.gov/dm/pubs/statistics/ #Gestational
4. Izzo T, Lo Dico G, Richiusa P. Pregnancy, gestational diabetes, thyroid function: Our experience. Giornale Italiano di Ostetricia e Ginecologia. 2013;35: 466-470
5. Vojvodí L, Suloví V, Terzí M. Course and outcome of pregnancy in patients with hypothyroidism [in Serbian]. Srp Arh Celok Lek. 1992;121:62-64
6. Olivieri A, Valensise H, Magnani F, et al. High frequency of antithyroid autoantibodies in pregnant women at increased risk of gestational diabetes mellitus. Eur J Endocrinol. 2000;143:741-747
7. Agarwal MM, Dhatt GS, Punnose J, Bishawi B, Zayed R. Thyroid function abnormalities and antithyroid antibody prevalence in pregnant women at high risk for gestational diabetes mellitus. Gynecol Endocrinol. 2006;22:261-266
8. Mannisto T, Mendola P, Grewal J, Xie Y, Chen Z, Laughon SK. Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort. J Clin Endocrinol Metab. 2013;98:2725-2733
9. Wikner BN, Sparre LS, Stiller CO, Källén B, Asker C. Maternal use of thyroid hormones in pregnancy and neonatal outcome. Acta Obstet Gynecol SCAnd. 2008;87:617-627
10. Sinclair JC, Bracken MB. CliniCAlly useful measures of effect in binary analyses of randomized trials. J Clin EpiDemiol. 1994;47:881-889
11. CAsey BM, Dashe JS, Spong CY, McIntire DD, Leveno KJ, Cunningham GF. Perinatal signifiCAnce of isolated maternal hypothyroxinemia iDentified in the first half of pregnancy. Obstet Gynecol. 2007;109:1129-1135
12. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, et al. Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol. 2008;112:85-92
13. Karakosta P, Alegakis D, Georgiou V, et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab. 2012;97: 4464-4472
14. Männistö T, Väärasmäki M, Pouta A, et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy compliCAtions and maternal morbidity in later life. J Clin Endocrinol Metab. 2010;95:1084-1094
15. Sahu MT, Das V, Mittal S, Agarwal A, Sahu M. Overt and subcliniCAl thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet. 2010;281:215-220
16. TuDela CM, CAsey BM, McIntire DD, Cunningham FG. Relationship of subcliniCAl thyroid disease to the inciDence of gestational diabetes. Obstet Gynecol. 2012;119:983-988
17. Bazelier M, De Boer A, De Vries F. Acid suppressants and hip fracture: dupliCAte publiCAtion bias? Bone. 2012;49:920; author reply 921
18. Van Den Boogaard E, Vissenberg R, Land JA, et al. SignifiCAnce of (sub)cliniCAl thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update. 2011;17:605-619
19. Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011;75:1-9
20. Garduno-Garcia JDe J, AlvirDe-Garcia U, López-CArrasco G, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010;163:273-278
21. Handisurya A, Pacini G, Tura A, Gessl A, Kautzky-Willer A. Effects of T4 replacement therapy on glucose metabolism in subjects with subcliniCAl (SH) and overt hypothyroidism (OH). Clin Endocrinol (Oxf). 2008;69: 963-969
22. Dimitriadis G, Mitrou P, Lambadiari V, et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrinol Metab. 2006;91:4930-4937
23. Maratou E, Hadjidakis DJ, Kollias A, et al. Studies of insulin resistance in patients with cliniCAl and subcliniCAl hypothyroidism. Eur J Endocrinol. 2009;160:785-790
24. Hawkes WC, Alkan Z, Lang K, King JC. Plasma selenium Decrease during pregnancy is associated with glucose intolerance. Biol Trace Elem Res. 2004;100:19-29
25. Lambadiari V, Mitrou P, Maratou E, et al. Thyroid hormones are positively associated with insulin resistance early in the Development of type 2 diabetes. Endocrine. 2011;39:28-32
26. Dittrich R, Kajaia N, Cupisti S, Hoffmann I, Beckmann MW, Mueller A. Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS. Reprod Biomed Online. 2009;19:319-325
27. Mueller A, Schöfl C, Dittrich R, et al. Thyroid-stimulating hormone is associated with insulin resistance inDepenDently of body mass inDex and age in women with polycystic ovary syndrome. Hum Reprod. 2009;24:2924-2930
28. Bilic-Komarica E, Beciragic A, Junuzovic D. Effects of treatment with L-thyroxin on glucose regulation in patients with subcliniCAl hypothyroidism. Med Arh. 2012;66: 364-368
29. Luo L, Yano N, Luo JZ. The molecular mechanism of EGF receptor activation in pancreatic beta-cells by thyrotropin-releasing hormone. Am J Physiol Endocrinol Metab. 2006;290:E889-899
30. Matejková-Behanová M, Zamrazil V, Vondra K, et al. Autoimmune thyroiditis in non-obese subjects with initial diagnosis of Type 2 diabetes mellitus. J Endocrinol Invest. 2002;25:779-784
31. Mulla CM, Geras-Raaka E, Raaka BM, Gershengorn MC. High levels of thyrotropin-releasing hormone receptors activate programmed cell Death in human pancreatic precursors. Pancreas. 2009;38:197-202
32. Abbassi-Ghanavati M, CAsey BM, Spong CY, McIntire DD, Halvorson LM, Cunningham FG. Pregnancy outcomes in women with thyroid peroxidase antibodies. Obstet Gynecol. 2010;116:381-386
33. Feki M, Omar S, Menif O, et al. Thyroid disorDers in pregnancy: frequency and association with selected diseases and obstetriCAl compliCAtions in Tunisian women. Clin Biochem. 2008;41:927-931
34. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A. Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab. 2011;96: E920-924
35. Walker E, HernanDez AV, Kattan MW. Meta-analysis: Its strengths and limitations. Cleve Clin J Med. 2008;75: 431-439
36. Kontopantelis E, Springate DA, Reeves D. A re-analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta-analyses. PLoS One. 2013;8:e69930
37. Toulis KA, Goulis DG, Kolibianakis EM, Venetis CA, Tarlatzis BC, Papadimas I. Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Fertil Steril. 2009; 92:667-677